Background

LSB MedTech Group Ltd is headquartered in the United Arab Emirates, with several branch offices in Europe. Until mid-2018, LSB MedTech was a co-owner and investor in Vitak Group Ltd, alongside Maastricht University. Vitak Group Ltd, a subsidiary of Maastricht University, was the world’s largest MGP CRO laboratory. It had its own Medical Technology division, which focused on medical devices for monitoring vascular elasticity and anticoagulants, as well as a Pharma division specializing in vitamin K antagonists and vascular calcification.

As a spin-out company,LSB MedTech specializes in the development of medical devices, innovation consultancy, and the valorization of intellectual property (IP). Over recent years, LSB MedTech has successfully developed, patented, and licensed several medical devices and technologies.

In 2018, LSB MedTech established its own CRO laboratory in collaboration with several academic institutions, providing CRO services to pharmaceutical companies and the food industry.

Since 2021, LSB MedTech has been offering innovation consultancy services related to patient care solutions for nursing homes and hospitals, aiming to improve the quality of life for patients.

In mid-2023, our CRO Laboratory activities were taken over. Since then, we have continued our medical innovation technology activities, innovation consulting, and IP valorization under the name LSB MedTech. These activities are conducted from our offices in the UAE and partially in the Netherlands.

In 2023, LSB MedTech, in collaboration with several universities, developed Prone & Supine courses for our training platform. These courses demonstrate our commitment to safety, early intervention, and the education of evidence-based practices related to prone positioning. LSB MedTech offers various forms of courses for hospitals and homecare organizations.